As the body of peer-reviewed research on cognitive-function ingredients continues to grow, omega-3 is just the tip of the iceberg for natural alternatives to prescription drugs, say industry experts.
Is the media accurately reporting the results of the latest dietary supplement research? If not, what should the industry do? If so, what can the industry do? Manufacturers have been grappling with these questions for the past several years and may be closer to finding some answers.
Chances are increasingly slim that the country will escape the twin epidemics of diabetes and obesity if present trends continue. More than 20 million Americans already have diabetes, and more than 60 million Americans are obese. The two conditions have become so intertwined that experts recently coined a term to describe their relationship: diabesity.
Congress recognized that food allergies are a significant problem, and it determined that allergic consumers or caregivers have to make appropriate food selections based on accurate labeling of food products.
Until recently, the federal government had said very little about what constitutes a whole-grain food. That changed on February 17, when the Food and Drug Administration (FDA; Rockville, MD) issued a draft guidance document clarifying its views.
The concept of branding an ingredient has become more and more popular over the past 10 years, and it remains a viable way for suppliers to help differentiate their products within the marketplace.
The good news is that there’s growing evidence nutritional supplements can play a key role in treating people with heart disease.
Jonathan Emord knows a thing or two about the Food and Drug Administration (FDA; Rockville, MD). He has defeated the agency in federal court a record six times and served as plaintiff’s lead counsel in the 1999 Pearson v. Shalala, 2001 Pearson v. Shalala, 2001 Pearson v. Thompson, and 2002 Whitaker v. Thompson cases.
Does your brand have what it takes to be honest in a highly competitive market? More importantly, can a brand ever afford to be less than honest when telling what, of necessity, must be a compelling story?
One of the most important studies on natural ingredients of the past decade will soon have a postscript. The Age-Related Eye Disease Study (AREDS), published in the October 2001 issue of Archives of Ophthalmology, was the first large-scale clinical trial to confirm that antioxidant supplementation may help slow down the progression of advanced age-related macular degeneration (AMD).